Common Deal Structures: SAFEs, Convertible Notes, and Priced Rounds Compared

When you invest in a private company, you’re not just buying a stake — you’re signing a contract that determines when you become a shareholder, at what price, and what standing you have if the company never raises again. Three instruments dominate early-stage private deals: SAFEs, convertible notes, and priced equity rounds. Knowing what you’re holding changes how you read everything else.

The Question Behind the Question

Before comparing instruments, there’s one foundational question worth sitting with: when does your investment become equity?

In a priced round, the answer is the moment the round closes. You invest, shares are issued, and your ownership percentage is set. With a SAFE or convertible note, you hand over capital now and receive shares later — at a future event, usually a new funding round. Until that conversion happens, you’re an investor but not yet a shareholder of record.

That distinction is not a technicality. It affects your rights, your standing in a sale, and what happens if the company winds down before ever raising again.

SAFEs: Simple Agreements for Future Equity

A SAFE is a one-way bet on the company’s future. You invest a fixed amount today; in return, the company promises to issue you shares when it raises a qualifying priced round — at a price more favorable than what that round’s investors will pay.

SAFEs have no interest rate. No maturity date. No repayment obligation. If the company never raises a qualifying round, your SAFE may never convert, and depending on the document’s terms, you may have limited recourse.

Two terms control how favorable your conversion price will be:

Valuation cap sets a ceiling on the price at which your SAFE converts, regardless of how high the next round’s valuation goes. A $5M cap on a company that raises its Series A at $15M means you convert as if the company were worth $5M — giving you significantly more shares for the same dollars as the new investors.

Discount rate lets you convert at a fixed percentage below whatever the next round pays. A 20% discount means you pay $0.80 for every dollar of share price that Series A investors pay.

Most SAFEs carry one or both. When both apply, whichever produces the better price for you typically governs. The majority of SAFEs issued today are post-money SAFEs — the cap is calculated after your investment is included, which makes ownership math more predictable for everyone.

One term worth hunting for: a most-favored-nation (MFN) clause. If the company later issues a SAFE with better terms than yours, an MFN provision automatically updates your SAFE to match. It’s not universal, but it’s worth asking about.

Convertible Notes: Debt Designed to Become Equity

A convertible note is a loan with an unusual exit ramp: instead of being repaid in cash, it’s designed to convert into equity at the next funding round. Like any loan, it carries an interest rate (typically 4–8% annually) and a maturity date — usually 18 to 24 months — by which conversion is expected to have happened.

Convertible notes use the same cap and discount mechanics as SAFEs. The structural differences come down to three things:

The maturity date creates leverage. If the company reaches maturity without a qualifying round, it must repay the principal and accrued interest — or negotiate with noteholders to extend. That obligation gives you a position that SAFE holders don’t have if things stall.

Interest accrues in your favor. The principal that converts isn’t just what you invested — it’s your original check plus interest. Over 18–24 months at 5–6%, that’s a modest but real difference in the share count you receive.

Debt ranks above equity in liquidation. In a worst-case wind-down, noteholders have a claim on company assets before shareholders do. SAFEs, depending on their terms, often sit alongside or below common equity.

Convertible notes preceded SAFEs and remain common, especially in bridge rounds — small raises between larger priced rounds — where the company needs capital quickly and wants to defer valuation negotiations. Investors who prefer the maturity date protection, or who are simply more comfortable with debt instruments, still reach for notes.

Priced Rounds: Equity Now, Terms Set Today

In a priced round, the company and its investors agree on a valuation, shares are issued at a price per share that reflects that valuation, and you become a shareholder of record the moment the round closes. No future conversion event. No uncertainty about your ownership percentage. You know what you own.

Priced rounds are more complex and expensive to execute — they require a full term sheet, a certificate of incorporation amendment to authorize a new share class, and a stock purchase agreement. That overhead is why early-stage companies often use SAFEs or notes instead. By Series A, most rounds are priced.

The investor-facing advantage is immediate, defined rights. The share class you receive — almost always preferred stock in institutional rounds — carries explicit terms: liquidation preference, anti-dilution protection, information rights, and sometimes pro-rata rights for future rounds. As covered in the , those terms vary and are worth reading in the actual documents, not just the summary.

Liquidation preference is especially worth understanding. Preferred shareholders get their investment back — and sometimes a multiple of it — before common shareholders participate in proceeds from a sale or dissolution. In a priced round, you’ll know exactly what your preference is at the time you invest.

How the Three Compare

No instrument is inherently better. SAFEs are fast and founder-friendly. Notes give investors a maturity backstop. Priced rounds give investors immediate equity with defined rights. The right one depends on the company’s stage, the deal terms, and what you’re willing to accept in exchange for access.

What the Documents Actually Say

The instrument type tells you the shape of the deal. The specific terms tell you the economics. Before investing in any of the three, locate answers to these:

• What is the valuation cap, and is it pre-money or post-money?
• Is there a discount rate, and which applies if both are present?
• For SAFEs and notes: what happens in a sale or dissolution before conversion?
• For convertible notes: what happens at maturity if no qualifying round has closed?
• For priced rounds: what are the liquidation preference terms — 1x non-participating, 1x participating, or something else?
• Is there an MFN clause? A pro-rata right for future rounds?

For Reg CF and Reg A+ offerings, the Form C or offering circular filed with the SEC will specify the instrument type and its material terms. That filing — not the campaign page — is the document that governs. The is useful background for understanding the regulatory framework around the deal.

The Thing Worth Remembering

Knowing your instrument doesn’t tell you whether a company is worth backing. It tells you what you’ll own if things go well, what standing you have if they don’t, and when you’ll find out your actual ownership percentage. All three of those matter. Read what you’re signing.

This article is for educational purposes only and does not constitute investment, legal, or financial advice. Private market investing involves significant risk, including the potential loss of your entire investment. Consult a qualified financial or legal advisor before making investment decisions.